- Report
- March 2026
- 139 Pages
United States
From €2702EUR$2,999USD£2,317GBP
€3603EUR$3,999USD£3,090GBP
- Report
- July 2026
- 125 Pages
Europe
From €4280EUR$4,750USD£3,670GBP
- Report
- May 2026
- 180 Pages
United States
From €4280EUR$4,750USD£3,670GBP
- Report
- February 2026
- 108 Pages
Europe
From €5402EUR$5,995USD£4,632GBP
- Report
- February 2026
- 85 Pages
North America
From €5402EUR$5,995USD£4,632GBP
- Report
- March 2026
- 150 Pages
United States
From €4370EUR$4,850USD£3,747GBP
- Report
- March 2026
- 220 Pages
United States
From €4370EUR$4,850USD£3,747GBP
- Report
- February 2026
- 388 Pages
United States
From €4370EUR$4,850USD£3,747GBP
- Report
- October 2025
- 91 Pages
Middle East
From €4055EUR$4,500USD£3,477GBP
From €4055EUR$4,500USD£3,477GBP
- Report
- October 2023
- 428 Pages
Global
From €5250EUR$6,031USD£4,350GBP
- Report
- July 2024
- 288 Pages
Global
From €5250EUR$6,031USD£4,350GBP
- Report
- September 2024
- 593 Pages
Global
From €4324EUR$4,799USD£3,708GBP
- Report
- October 2018
- 450 Pages
Global
From €3153EUR$3,499USD£2,704GBP
- Report
- July 2024
- 154 Pages
Global
From €3469EUR$3,850USD£2,975GBP
- Report
- November 2024
- 185 Pages
Global
From €3469EUR$3,850USD£2,975GBP
- Report
- January 2024
Global
From €4370EUR$4,850USD£3,747GBP
- Report
- December 2023
- 217 Pages
Global
From €4370EUR$4,850USD£3,747GBP
- Report
- September 2023
- 234 Pages
Global
From €4370EUR$4,850USD£3,747GBP
- Report
- June 2023
- 235 Pages
Global
From €4370EUR$4,850USD£3,747GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more